Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Clinical trial NCT03172936 · TERMINATED
Trial details
- NCT number
- NCT03172936
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2020-12-18
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.